201 related articles for article (PubMed ID: 32001339)
1. Reshaping nanobodies for affinity purification on protein a.
Crauwels M; Van Vaerenbergh N; Kulaya NB; Vincke C; D'Huyvetter M; Devoogdt N; Muyldermans S; Xavier C
N Biotechnol; 2020 Jul; 57():20-28. PubMed ID: 32001339
[TBL] [Abstract][Full Text] [Related]
2. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein.
Salema V; Fernández LÁ
Protein Expr Purif; 2013 Sep; 91(1):42-8. PubMed ID: 23856605
[TBL] [Abstract][Full Text] [Related]
3. One-step orientated immobilization of nanobodies and its application for immunoglobulin purification.
Fu J; Li J; Wang W; Wu H; Zhou P; Li Y; He Q; Tu Z
J Chromatogr A; 2019 Oct; 1603():15-22. PubMed ID: 31213362
[TBL] [Abstract][Full Text] [Related]
4. Nanobodies Based on a Sandwich Immunoassay for the Detection of Staphylococcal Enterotoxin B Free from Interference by Protein A.
Ji Y; Li X; Lu Y; Guo P; Zhang G; Wang Y; Zhang Y; Zhu W; Pan J; Wang J
J Agric Food Chem; 2020 May; 68(21):5959-5968. PubMed ID: 32374597
[TBL] [Abstract][Full Text] [Related]
5. A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
[TBL] [Abstract][Full Text] [Related]
6. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
7. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
[TBL] [Abstract][Full Text] [Related]
8. An engineered Staphylococcal Protein A based ligand: Production, characterization and potential application for the capture of Immunoglobulin and Fc-fusion proteins.
Kangwa M; Yelemane V; Ponnurangam A; Fernández-Lahore M
Protein Expr Purif; 2019 Mar; 155():27-34. PubMed ID: 30445097
[TBL] [Abstract][Full Text] [Related]
9. Characterization and comparison of two peptide-tag specific nanobodies for immunoaffinity chromatography.
Ren J; Zhang C; Ji F; Jia L
J Chromatogr A; 2020 Aug; 1624():461227. PubMed ID: 32540069
[TBL] [Abstract][Full Text] [Related]
10. Structural evaluation of an alternative Protein A biomimetic ligand for antibody purification.
Barroso T; Branco RJ; Aguiar-Ricardo A; Roque AC
J Comput Aided Mol Des; 2014 Jan; 28(1):25-34. PubMed ID: 24390720
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rabbit polyclonal antibody against camel recombinant nanobodies.
Khalaf HE; Al-Bouqaee H; Hwijeh M; Abbady AQ
Open Life Sci; 2022; 17(1):659-675. PubMed ID: 35800073
[TBL] [Abstract][Full Text] [Related]
12. Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes.
Fridy PC; Thompson MK; Ketaren NE; Rout MP
Anal Biochem; 2015 May; 477():92-4. PubMed ID: 25707320
[TBL] [Abstract][Full Text] [Related]
13. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
[TBL] [Abstract][Full Text] [Related]
14. Nanobody production can be simplified by direct secretion from Escherichia coli.
Iwaki T; Hara K; Umemura K
Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
[TBL] [Abstract][Full Text] [Related]
15. Improving the tolerance of a protein a analogue to repeated alkaline exposures using a bypass mutagenesis approach.
Linhult M; Gülich S; Gräslund T; Simon A; Karlsson M; Sjöberg A; Nord K; Hober S
Proteins; 2004 May; 55(2):407-16. PubMed ID: 15048831
[TBL] [Abstract][Full Text] [Related]
16. Immobilization of Bioactive Protein A from Staphylococcus aureus (SpA) on the Surface of Bacillus subtilis Spores.
Ghaedmohammadi S; Rigi G; Zadmard R; Ricca E; Ahmadian G
Mol Biotechnol; 2015 Aug; 57(8):756-66. PubMed ID: 25840905
[TBL] [Abstract][Full Text] [Related]
17. Functional integration of protein A binding ability to antibody fragments for convenient and tag-free purification.
Kuwahara A; Nazuka M; Kuroki Y; Ito K; Watanabe S; Kumagai I; Asano R
Bioengineered; 2023 Dec; 14(1):2259093. PubMed ID: 37732741
[TBL] [Abstract][Full Text] [Related]
18. Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies.
Takeuchi H; Nakajima C; Konnai S; Maekawa N; Okagawa T; Usui M; Tamura Y; Suzuki Y; Murata S; Ohashi K
PLoS One; 2023; 18(1):e0281171. PubMed ID: 36701408
[TBL] [Abstract][Full Text] [Related]
19. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
20. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
